The management of N2 disease in non-small cell lung cancer
Symposium Chairs: J. Cadranel (Paris, France), J-P. Sculier (Brussels, Belgium)
Aims: The audience should learn how to diagnose and treat in 2013 stage IIIAN2 NSCLC, according to the level of evidence of the available tests and therapies.